The use of a femoral revision stem in the treatment of primary or secondary bone tumours of the proximal femur: A prospective study of 31 cases

Journal of Bone and Joint Surgery - Series B

Volumn 92, Issue 10, 2010, Pages 1435-1441

  Bischel, O E ^a,b   Bohm P M ^a,c  

^a High Tech Clinic   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Zentrum für Orthopädie High Tech Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE PROSTHESIS; BONE RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; FEMALE; FEMUR TUMOR; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; FEMORAL NEOPLASMS; HIP JOINT; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; REOPERATION; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957825465     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B10.24024     Document Type: Article

References (57)

1. American Cancer Society. Cancer, Facts and Figures 2007. Atlanta: American Cancer Society, 2007. http://www.cancer.org/docroot/CRI/content/CRI-2- 2-1X-How-many-people-get-bone-metastasis-66.asp (date last accessed 19 August 2009).
2. Capanna R, Campanacci DA. The treatment of metastases in the appendicular skeleton. J Bone Joint Surg [Br] 2001;83-B:471-81.
3. Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop 1989;249:256-64. (Pubitemid 20199775)
4. Böhm P, Huber J. The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg [Br] 2002;84-B:521-9. (Pubitemid 34578501)
5. Katzer A, Meenen NM, Grabbe F, Rueger JM. Surgery of skeletal metastases. Arch Orthop Trauma Surg 2002;122:251-8.
6. Toma CD, Dominkus M, Nedelcu T, et al. Metastatic bone disease: a 36-year single centre trend-analysis of patients admitted to a tertiary orthopaedic surgical department. J Surg Oncol 2007;96:404-10. (Pubitemid 47519446)
7. Kabukcuoglu Y. Grimer RJ, Tillman RM, Carter SR. Endoprosthetic replacement for primary malignant tumours of the proximal femur. Clin Orthop 1999;358:8-14. (Pubitemid 29066069)
8. Rougraff BT, Simon M, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur: a long-term oncological, functional, and quality-of-life study. J Bone Joint Surg [Am] 1994;76-A:649-56. (Pubitemid 24180973)
9. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg [Am] 1986;68-A:1331-7. (Pubitemid 17232206)
10. Böhm P, Raecke O. Multimodal interdisciplinary therapy to improve function and long-term survival in patients with high-grade osteosarcoma of the extremities. Chirurg 2002;73:809-17 (in German).
11. Chao ETS, Sim FH, Shives TC, Pritchard DJ. Management of pathologic fracture: biomechanical considerations. In: Sim FH, ed. Diagnosis and management of metastatic bone disease: a multidisciplinary approach. New York: Raven Press, 1988:171.
12. Dijstra S, Wiggers T, van Geel BN, Boxma H. Impending and actual pathological fractures in patients with bone metastases of the long bones: a retrospective study of 233 surgically treated fractures. Eur J Surg 1994;160:535-42. (Pubitemid 24325837)
13. Fuchs B, Trousdale RT, Rock MG. Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment. Clin Orthop 2005;431:187-92. (Pubitemid 40194235)
14. Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg [Br] 2005;87-B:1653-7.
15. Yazawa Y, Frassica FJ, Chao EY, et al. Metastatic bone disease: a study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop 1990;251:213-19. (Pubitemid 20088647)
16. Haentjens P, de Neve W, Casteleyn PP, Opdecam P. Massive resection and prosthetic replacement for the treatment of metastases of the trochanteric and subtrochanteric femoral region bipolar arthroplasty versus total hip arthroplasty. Acta Orthop Belg 1993;59(Suppl 1):367-71.
17. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg [Am] 1995;77-A:1154-65.
18. Unwin PS, Cannon SR, Grimer RJ, et al. Aseptic loosening in cemented custommade prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg [Br] 1996;78-B:5-13.
19. Böhm P, Bischel O. Femoral revision with the Wagner SL revision stem: evaluation of one hundred and twenty-nine revisions followed for a mean of 4.8 years. J Bone Joint Surg [Am] 2001;83-A:1023-31. (Pubitemid 32662104)
20. Böhm P, Bischel O. The use of tapered stems for femoral revision surgery. Clin Orthop 2004;420:148-59. (Pubitemid 38436571)
21. Böhm P, Fritz J, Thiede S, Budach W. Reimplantation of extracorporeal irradiated bone segments in musculoskeletal tumor surgery: clinical experience in eight patients and review of the literature. Langenbecks Arch Surg 2003;387:355-65. (Pubitemid 36187846)
22. Karnofsky DA, Burchenal JH.The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM ed. Evaluation of chemotherapeutic agents. New York: Columbia Universuity Press, 1949:196.
23. Enneking WF, Dunham W, Gebhardt MC, Malawar M , Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 1993;286:241-6. (Pubitemid 23059493)
24. Merle d'Aubigné R. Numerical evaluation of hip function. Rev Chir Orthop Reparatrice Appar Mot 1970;56:481-6 (in French).
25. Callaghan JJ, Salvati EA, Pellicci PM, Wilson PD Jr, Ranawat CS. Results of revision for mechanical failure after cemented total hip replacement, 1979 to 1982: a two to five-year follow-up. J Bone Joint Surg [Am] 1985;67-A:1074-85.
26. Engh CA, Massin P. Cementless total hip arthroplasty using the anatomic medullary locking stem: results using a survivorship analysis. Clin Orthop 1989;249:141-58. (Pubitemid 20199764)
27. Talbot M, Turcotte RE, Isler M, et al. Function and health status in surgically treated bone metastases. Clin Orthop 2005;438:215-20. (Pubitemid 41254340)
28. Hansen BH, Keller J, Laitinen M, et al. The Scandinacian Sarcoma Group Skeletal Metastasis Register: survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl 2004;75:11-15. (Pubitemid 38580808)
29. Katagiri H, Takahashi M, Wakai K, et al. Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg [Br] 2005;87-B:698-703. (Pubitemid 40711646)
30. Rompe JD, Eysel P, Hopf C, Heine J. Metastatic instability at the proximal end of the femur: comparison of endoprosthetic replacement and plate osteosynthesis. Arch Orthop Trauma Surg 1994;113:260-4. (Pubitemid 24247609)
31. Wedin R. Surgical treatment for pathologic fracture. Acta Orthop Scand Suppl 2001;72:1-29.
32. Lee KA, Nicholas RW, Rougraff B, et al. Local progression after operative treatment of metastatic kidney cancer. Clin Orthop 2001;390:206-11. (Pubitemid 32816793)
33. Ogilvie CM, Wunder JS, Ferguson PC, Griffin AM, Bell RS. Functional outcome of endoprosthetic proximal femoral replacement. Clin Orthop 2004;426:44-8.
34. Mittermayer F, Krepler P, Dominkus M, et al. Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop 2001;388:167-77. (Pubitemid 32595020)
35. Morris HG, Capanna R, Del Ben M, Campanacci D. Prosthetic reconstruction of the proximal femur after resection for bone tumors. J Arthroplasty 1995;10:293-9.
36. Zehr RJ, Enneking WF, Scarborough MT. Allograft-prosthesis composite versus megaprosthesis in proximal femoral reconstruction. Clin Orthop 1996;322:207-23.
37. Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu AT. Modular endoprosthetic replacement for metastatic tumours of the proximal femur. J Orthop Surg 2008;3:50.
38. Bruns J, Delling G, Gruber H, Lohmann CH, Habermann CR. Cementless fixation of megaprostheses using a conical fluted stem in the treatment of bone tumours. J Bone Joint Surg [Br] 2007;89-B:1084-7. (Pubitemid 47492806)
39. Clarke HD, Damron TA, Sim FH. Head and neck replacement endoprosthesis for pathologic proximal femoral lesions. Clin Orthop 1998;353:210-17.
40. Jacofsky DJ, Haidukewych GJ, Zhang H, Sim FH. Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip. Clin Orthop 2004;427:52-6. (Pubitemid 39362830)
41. Torbert JT, Fox EJ, Hosalkar HS, Ogilvie CM, Lackman RD. Endoprosthetic reconstructions: results of long-term followup of 139 patients. Clin Orthop 2005;438:51-9.
42. Hanna SA, Sewell MD, Aston WJ, et al. Femoral diaphyseal endoprosthetic reconstruction after segmental resection of primary bone tumours. J Bone Joint Surg [Br] 2010;92-B:867-74.
43. Sewell MD, Spiegelberg BG, Hanna SA, et al. Total femoral endoprosthetic replacement following excision of bone tumours. J Bone Joint Surg [Br] 2009;91-B:1513-20.
44. Chandrasekar CR, Grimer RJ, Carter ST, et al. Modular endoprostheic replacement for tumours of the proxiaml femur. J Bone Joint Surg [Br] 2009;91-B:108-12.
45. Grimer RJ, Bielack S, Flege S, et al; European Musculo Skeletal Oncology Society. Periosteal osteosarcoma: a European review of outcome. Eur J Cancer 2005;41:2806-11.
46. Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcoma: a center-based study of 69 cases. Cancer 2001;91:1201-12. (Pubitemid 32267029)
47. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-90. (Pubitemid 34111386)
48. Manoso MW, Healey JH, Boland PJ, et al. De novo osteogenic sarcoma in patients older than forty: benefit of multimodality therapy. Clin Orthop 2005;438:110-15.
49. Sluga M, Windhager R, Pfeiffer M, et al. Osteosarcoma and Ewing's sarcoma: the most frequent malignant bone tumors in children: therapy and outcome. Z Orthop Ihre Grenzgeb 2002;140:652-5. (Pubitemid 36071814)
50. Aksnes LH, Hall KS, Folleraas G, et al. Management of high-grade bone sarcomas over two decades: the Norwegian Radium Hospital experience. Acta Oncol 2006;45:38-46. (Pubitemid 43214640)
51. Ferrari S, Bertoni F, Mercuri M, et al. Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 2001;12:1145-50. (Pubitemid 32834497)
52. Raman R, Kamath RP, Parikh A, Angus PD. Revision of cemented hip arthroplasty using a hydroxyapatite-ceramic-coated femoral component. J Bone Joint Surg [Br] 2005;87-B:1061-7. (Pubitemid 41131552)
53. Trikha SP, Singh S, Raynham OW, et al. Hydroxyapatite-ceramic-coated femoral stems in revision hip surgery. J Bone Joint Surg [Br] 2005;87-B:1055-60. (Pubitemid 41131551)
54. Malkani AL, Settecerri JJ, Sim FH, Chao EY, Wallrichs SL. Long-term results of proximal femoral replacement for non-neoplastic disorders. J Bone Joint Surg [Br] 1995;77-B:351-6.
55. Parvizi J, Tarity TD, Slenker N, et al. Proximal femoral replacement in patients with non-neoplastic conditions. J Bone Joint Surg [Am] 2007;89-A:1036-43. (Pubitemid 46724594)
56. Dobbs HS, Scales JT, Wilson JN, et al. Endoprosthetic replacement of the proximal femur and acetabulum: a survival analysis. J Bone Joint Surg [Br] 1981;63-B:219-24.
57. Morris HG, Capanna R, Campanacci D, Del Ben M, Gasbarrini A. Modular endoprosthetic replacement after total resection of the femur for malignant tumour. Int Orthop 1994;18:90-5. (Pubitemid 24132416)